Marella Thorell is Chief Accounting Officer of Centessa Pharmaceuticals plc. Currently has a direct ownership of 53,101 shares of CNTA, which is worth approximately $897,406. The most recent transaction as insider was on Mar 21, 2022, when has been sold 52,101 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 53.1K
0% 3M change
0% 12M change
Total Value Held $897,406

Marella Thorell Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 21 2022
BUY
Other acquisition or disposition
-
52,101 Added 49.52%
53,101 Ordinary Shares
Jun 02 2021
BUY
Open market or private purchase
$20,000 $20.0 p/Share
1,000 Added 50.0%
1,000 Ordinary Shares

Also insider at

EPIX
ESSA Pharma Inc. Healthcare
VLON
Vallon Pharmaceuticals, Inc. Healthcare
MCRB
Seres Therapeutics, Inc. Healthcare
EVLO
Evelo Biosciences, Inc. Healthcare
SESN
Sesen Bio, Inc. Healthcare
MT

Marella Thorell

Chief Accounting Officer
Philadelphia, PA

Track Institutional and Insider Activities on CNTA

Follow Centessa Pharmaceuticals plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CNTA shares.

Notify only if

Insider Trading

Get notified when an Centessa Pharmaceuticals PLC insider buys or sells CNTA shares.

Notify only if

News

Receive news related to Centessa Pharmaceuticals plc

Track Activities on CNTA